These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19745645)

  • 1. Atomoxetine and cerebrovascular outcomes in adults.
    Holick CN; Turnbull BR; Jones ME; Chaudhry S; Bangs ME; Seeger JD
    J Clin Psychopharmacol; 2009 Oct; 29(5):453-60. PubMed ID: 19745645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
    De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
    J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications.
    McAfee AT; Landon J; Jones M; Bangs ME; Acharya N; Hornbuckle K; Wong J
    Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):386-93. PubMed ID: 23280590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD.
    Gerhard T; Winterstein AG; Olfson M; Huang C; Saidi A; Crystal S
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):457-64. PubMed ID: 20232490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of selecting atomoxetine therapy for children with attention-deficit-hyperactivity disorder.
    Van Brunt DL; Johnston JA; Ye W; Pohl GM; Sun PJ; Sterling KL; Davis ME
    Pharmacotherapy; 2005 Nov; 25(11):1541-9. PubMed ID: 16232017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA; Chalakova NT; Dimitrov BD
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased risk of stroke among 10-year survivors of breast cancer.
    Hooning MJ; Dorresteijn LD; Aleman BM; Kappelle AC; Klijn JG; Boogerd W; van Leeuwen FE
    J Clin Oncol; 2006 Dec; 24(34):5388-94. PubMed ID: 17088569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
    Mehta S; Johnson ML; Chen H; Aparasu RR
    J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD.
    Polzer J; Bangs ME; Zhang S; Dellva MA; Tauscher-Wisniewski S; Acharya N; Watson SB; Allen AJ; Wilens TE
    Biol Psychiatry; 2007 Mar; 61(5):713-9. PubMed ID: 16996485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
    Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
    Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy with atomoxetine for US children and adolescents.
    Bhatara VS; Aparasu RR
    Ann Clin Psychiatry; 2007; 19(3):175-80. PubMed ID: 17729019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
    van Goor MP; Alblas CL; Leebeek FW; Koudstaal PJ; Dippel DW
    Acta Neurol Scand; 2004 Jun; 109(6):410-5. PubMed ID: 15147465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased use of clonidine following treatment with atomoxetine in children with ADHD.
    Johnston JA; Ye W; Van Brunt DL; Pohl G; Sumner CR
    J Clin Psychopharmacol; 2006 Aug; 26(4):389-95. PubMed ID: 16855457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine.
    Wernicke JF; Holdridge KC; Jin L; Edison T; Zhang S; Bangs ME; Allen AJ; Ball S; Dunn D
    Dev Med Child Neurol; 2007 Jul; 49(7):498-502. PubMed ID: 17593120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of cerebrovascular accidents after percutaneous coronary interventions.
    Dukkipati S; O'Neill WW; Harjai KJ; Sanders WP; Deo D; Boura JA; Bartholomew BA; Yerkey MW; Sadeghi HM; Kahn JK
    J Am Coll Cardiol; 2004 Apr; 43(7):1161-7. PubMed ID: 15063423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
    Wilens TE; Adler LA; Weiss MD; Michelson D; Ramsey JL; Moore RJ; Renard D; Brady KT; Trzepacz PT; Schuh LM; Ahrbecker LM; Levine LR;
    Drug Alcohol Depend; 2008 Jul; 96(1-2):145-54. PubMed ID: 18403134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.